Internal Medicine · Richmond, VA
NPI
1770570657
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1250 E Marshall St, Dept. of Internal Medicine-Gen. Med./Primary Care
Richmond, VA, 23298
Phone (804) 828-9357
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,602
227 services
Medicare patients, 2024
48
Average age 39
Drug cost, 2024
$1.9M
1,754 prescriptions
Company payments, 2025
$27.21
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thokozeni Lipato was code 99214 (office e&m - established), 90 times for 39 patients. In total Thokozeni Lipato billed 227 services in 6 codes, and Medicare paid $9,602.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-10-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 90 | 39 | $65.17 | $5,865 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 80 | 36 | $12.46 | $997 |
| 99213 Office E&M - Established | Facility | 50 | 29 | $47.80 | $2,390 |
By year: 2022 $15K for 357 services; 2023 $7,044 for 114 services; 2024 $9,602 for 227 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thokozeni Lipato prescribed most often to Medicare patients was Oxycodone Hcl, with 382 prescriptions and refills. In total Thokozeni Lipato wrote 1,754 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 382 | 382 | 60 | $27K |
| Hydroxyurea Generic | 189 | 284 | 58 | $5,834 |
| Oxbryta Voxelotor | 128 | 128 | 27 | $1.5M |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 99 | 99 | 16 | $5,870 |
| Hydromorphone Hcl Generic | 82 | 82 | 24 | $3,605 |
| Methadone Hcl Generic | 62 | 62 | 11 | $1,389 |
| Morphine Sulfate Er Morphine Sulfate | 54 | 56 | 14 | $3,845 |
| Fentanyl Generic | 54 | 54 | Under 11 | $12K |
| Oxycontin Oxycodone Hcl | 48 | 48 | 11 | $65K |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 46 | 46 | Under 11 | $6,570 |
| Gabapentin Generic | 43 | 43 | Under 11 | $384 |
| Alprazolam Generic | 36 | 36 | Under 11 | $25.88 |
| Promethazine Hcl Generic | 30 | 30 | Under 11 | $88.65 |
| Morphine Sulfate Generic | 29 | 29 | Under 11 | $2,493 |
| Xtampza Er Oxycodone Myristate | 27 | 27 | Under 11 | $38K |
Brand drugs: 365 claims; generic drugs: 1,389 claims; opioid claims: 891.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thokozeni Lipato $27.21 ($27.21 in general payments such as food, travel and fees) from 4 companies. The largest payer was Agios Pharmaceuticals, Inc. with $27.21.
| Company | Payments | Amount |
|---|---|---|
| Agios Pharmaceuticals, Inc. AGIO | 1 | $27.21 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.